Literature DB >> 16980218

The role of mesenchymal cells in the pathophysiology of inflammatory arthritis.

Lars-Henrik Meyer1, Lars Franssen, Thomas Pap.   

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory disorder of the joints that can cause severe disability. While the role of inflammatory cells in the pathogenesis of RA has been well established, the specific contribution of resident cells within the synovial membrane, especially those of mesenchymal origin, has become the object of closer scrutiny only recently. The central position of these cells in the disease process of RA is underlined by their involvement in its main pathophysiological features: inflammation, hyperplasia and joint destruction. In this chapter, we provide a characterisation of resident mesenchymal cells, specifically fibroblast-like cells in the rheumatoid synovium, and give an overview of the molecular pathways by which these cells are involved in the initiation and perpetuation of RA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16980218     DOI: 10.1016/j.berh.2006.06.005

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  14 in total

1.  KCa1.1 potassium channels regulate key proinflammatory and invasive properties of fibroblast-like synoviocytes in rheumatoid arthritis.

Authors:  Xueyou Hu; Teresina Laragione; Liang Sun; Shyny Koshy; Karlie R Jones; Iskander I Ismailov; Patricia Yotnda; Frank T Horrigan; Pércio S Gulko; Christine Beeton
Journal:  J Biol Chem       Date:  2011-11-10       Impact factor: 5.157

Review 2.  Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis.

Authors:  Beatrix Bartok; Gary S Firestein
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

3.  Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis.

Authors:  Georgia Barouta; Christina G Katsiari; Ioannis Alexiou; Christos Liaskos; Areti Varna; Dimitrios P Bogdanos; Anastasios E Germenis; Lazaros I Sakkas
Journal:  Clin Rheumatol       Date:  2016-12-10       Impact factor: 2.980

4.  Slit3 inhibits Robo3-induced invasion of synovial fibroblasts in rheumatoid arthritis.

Authors:  Alexandra E Denk; Simone Kaufmann; Klaus Stark; Jörg Schedel; Torsten Lowin; Thomas Schubert; Anja K Bosserhoff
Journal:  Arthritis Res Ther       Date:  2010-03-18       Impact factor: 5.156

5.  Mast cells and hypoxia drive tissue metaplasia and heterotopic ossification in idiopathic arthrofibrosis after total knee arthroplasty.

Authors:  Theresa A Freeman; Javad Parvizi; Craig J Dela Valle; Marla J Steinbeck
Journal:  Fibrogenesis Tissue Repair       Date:  2010-09-01

6.  The tumour-associated glycoprotein podoplanin is expressed in fibroblast-like synoviocytes of the hyperplastic synovial lining layer in rheumatoid arthritis.

Authors:  Anna-Karin H Ekwall; Thomas Eisler; Christian Anderberg; Chunsheng Jin; Niclas Karlsson; Mikael Brisslert; Maria I Bokarewa
Journal:  Arthritis Res Ther       Date:  2011-03-07       Impact factor: 5.156

7.  Bio-imaging and Photodynamic Therapy with Tetra Sulphonatophenyl Porphyrin (TSPP)-TiO2 Nanowhiskers: New Approaches in Rheumatoid Arthritis Theranostics.

Authors:  Chunqiu Zhao; Fawad Ur Rehman; Yanlong Yang; Xiaoqi Li; Dong Zhang; Hui Jiang; Matthias Selke; Xuemei Wang; Chongyang Liu
Journal:  Sci Rep       Date:  2015-07-08       Impact factor: 4.379

8.  The anti-arthritic and immune-modulatory effects of NHAG: a novel glucosamine analogue in adjuvant-induced arthritis.

Authors:  Syed Uzair A Shah; Huma Jawed; Shahid I Awan; Shazia Anjum; Shabana U Simjee
Journal:  Biomed Res Int       Date:  2013-07-18       Impact factor: 3.411

9.  A systems approach to rheumatoid arthritis.

Authors:  Sungyong You; Chul-Soo Cho; Inyoul Lee; Leroy Hood; Daehee Hwang; Wan-Uk Kim
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

Review 10.  Cells of the synovium in rheumatoid arthritis. Chondrocytes.

Authors:  Miguel Otero; Mary B Goldring
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.